Important information about Maviret

MAVIRET is a prescription medicine containing a combination tablet of 100mg of glecaprevir and 40mg of pibrentasvir. It is used to treat chronic (long-lasting) hepatitis...   Read More

PHARMAC funding decision gives Kiwis with hepatitis C access to a potential cure

Life-changing treatment for New Zealanders living with hepatitis C will be available from February 1, 2019, after PHARMAC funds a new treatment. The medicine...   Read More

Changing the world, from New Zealand

Hep C Action Aotearoa is a small group with big ideas. Responding to the crippling stigma that surrounds the now curable infectious disease, they...   Read More

Health and safety work recognised

Staff well-being is hugely important for us. So it was great to be recognised as a finalist in the small enterprise category of this...   Read More

Nursing scholarship for Tarawera High student

Life just got easier for a Tarawera High School student beginning a nursing degree next year. Maria Mitchell has won a Hepatitis Foundation of...   Read More

Community pharmacies recruited for Waitemata DHB hepatitis C screening pilot

A potentially life-saving Waitemata DHB-funded hepatitis C screening programme is being trialed at seven west and north Auckland pharmacies. Around 500 participants considered to...   Read More

Towards WHO Viral Hepatitis Elimination 2030

By Dr Alex Lampen-Smith for the NZ Society of Gastroenterologists   In 2015 the World Health Organisation (WHO) outlined the goal of removing viral...   Read More

Liver testing opportunity for people living with hepatitis C

A FibroScan clinic for people living with hepatitis C will be held in Whakatane later this month.  The Midland Region Community Hepatitis C team,...   Read More

New patient management system part of hepatitis elimination strategy

A new patient management and registry system at the Hepatitis Foundation of NZ promises huge benefits. The move means the foundation has completed its...   Read More

Dr Homie Razavi – Eliminating Hepatitis C Listen here Dr Homie Razavi is the managing director at the Center for Disease Analysis (CDA) and the CDA Foundation and leads the...   Read More

© The Hepatitis Foundation of New Zealand 2016